Scientists from Boston University (BU) and the Wyss Institute at Harvard University have developed a new method called ESCAPE, which is engineered sacrificial capillary pumps for evacuation that could improve how tissue is fabricated and designed.
World Down Syndrome Day (WDSD) raises awareness and creates a single global voice for advocating for the rights, inclusion and well-being of people with Down Syndrome
Donald A. Mahler from the Geisel School of Medicine at Dartmouth and Clinical Resource Center of the Alpha-1 Foundation and Valley Regional Hospital, on behalf of the CHEST Foundation, provides an expert view on shortness of breath (dyspnea)
Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on nanomaterials in today’s healthcare sector, including therapeutic precision versus nanotoxicology risk.
Sorcha McPhillips, Chief Executive of the Huntington’s disease (HD) Association for Northern Ireland, raises awareness of HD and discusses the impact of hope on the community in the face of new treatments
Dr Paul De Raeve, Secretary-General of the European Federation of Nurses Associations (EFN) provides an in-depth perspective on the extent to which nurses in Europe are codesigning an EU value-based health and social care ecosystem.
Dr David Muss MD will deliver a one day workshop to hundreds of mental health professions to teach The Rewind technique which can help treat Post-Traumatic Stress Disorder (PTSD) patients
Jonathan Evans, communications manager at the Association of British Healthcare Industries explains the need to innovate when it comes to using digital technologies for the delivery of healthcare in the UK.
Life Science leaders from across the UK have welcomed a new agreement that will make it easier for life-changing clinical trials and medicines research and development to take place across different parts of the UK
In light of Rare Disease Day, EURORDIS – Rare Diseases Europe and its member organisations, have launched a new position paper today (28th February), to grant patients full access to rare disease therapies across Europe.
